nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—Benazepril—Lisinopril—dilated cardiomyopathy	0.663	1	CrCrCtD
Trimipramine—ABCB1—Lisinopril—dilated cardiomyopathy	0.0266	0.532	CbGbCtD
Trimipramine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0234	0.468	CbGbCtD
Trimipramine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00867	0.4	CbGeAlD
Trimipramine—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00729	0.0522	CcSEcCtD
Trimipramine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.00468	0.216	CbGeAlD
Trimipramine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00423	0.0303	CcSEcCtD
Trimipramine—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00332	0.0238	CcSEcCtD
Trimipramine—Ataxia—Spironolactone—dilated cardiomyopathy	0.00323	0.0231	CcSEcCtD
Trimipramine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00294	0.021	CcSEcCtD
Trimipramine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00289	0.133	CbGeAlD
Trimipramine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00286	0.0205	CcSEcCtD
Trimipramine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00281	0.13	CbGeAlD
Trimipramine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00273	0.0195	CcSEcCtD
Trimipramine—Throat sore—Lisinopril—dilated cardiomyopathy	0.00268	0.0192	CcSEcCtD
Trimipramine—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00266	0.019	CcSEcCtD
Trimipramine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00265	0.0189	CcSEcCtD
Trimipramine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00247	0.0177	CcSEcCtD
Trimipramine—Aprindine—SCN5A—dilated cardiomyopathy	0.00238	0.264	CrCbGaD
Trimipramine—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00212	0.0152	CcSEcCtD
Trimipramine—Alopecia—Spironolactone—dilated cardiomyopathy	0.0021	0.015	CcSEcCtD
Trimipramine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00209	0.0149	CcSEcCtD
Trimipramine—Purpura—Furosemide—dilated cardiomyopathy	0.00194	0.0139	CcSEcCtD
Trimipramine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00192	0.0137	CcSEcCtD
Trimipramine—Malaise—Spironolactone—dilated cardiomyopathy	0.00186	0.0133	CcSEcCtD
Trimipramine—Oxcarbazepine—SCN5A—dilated cardiomyopathy	0.00185	0.205	CrCbGaD
Trimipramine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00178	0.0127	CcSEcCtD
Trimipramine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00174	0.0124	CcSEcCtD
Trimipramine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0017	0.0122	CcSEcCtD
Trimipramine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00165	0.0118	CcSEcCtD
Trimipramine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.0016	0.0114	CcSEcCtD
Trimipramine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00151	0.0108	CcSEcCtD
Trimipramine—Somnolence—Spironolactone—dilated cardiomyopathy	0.0015	0.0107	CcSEcCtD
Trimipramine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00149	0.0107	CcSEcCtD
Trimipramine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00144	0.0103	CcSEcCtD
Trimipramine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00143	0.0102	CcSEcCtD
Trimipramine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00139	0.00994	CcSEcCtD
Trimipramine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00139	0.00994	CcSEcCtD
Trimipramine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00134	0.00961	CcSEcCtD
Trimipramine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00134	0.00959	CcSEcCtD
Trimipramine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00133	0.00954	CcSEcCtD
Trimipramine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00132	0.00942	CcSEcCtD
Trimipramine—Carbamazepine—SCN5A—dilated cardiomyopathy	0.00126	0.14	CrCbGaD
Trimipramine—Tinnitus—Furosemide—dilated cardiomyopathy	0.0012	0.00862	CcSEcCtD
Trimipramine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.0012	0.00858	CcSEcCtD
Trimipramine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00119	0.00854	CcSEcCtD
Trimipramine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00115	0.00826	CcSEcCtD
Trimipramine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00115	0.00826	CcSEcCtD
Trimipramine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00115	0.00823	CcSEcCtD
Trimipramine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00112	0.00798	CcSEcCtD
Trimipramine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00112	0.00798	CcSEcCtD
Trimipramine—Weight increased—Lisinopril—dilated cardiomyopathy	0.0011	0.00788	CcSEcCtD
Trimipramine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0011	0.00788	CcSEcCtD
Trimipramine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00107	0.00767	CcSEcCtD
Trimipramine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00106	0.00761	CcSEcCtD
Trimipramine—Rash—Spironolactone—dilated cardiomyopathy	0.00106	0.00761	CcSEcCtD
Trimipramine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00106	0.0076	CcSEcCtD
Trimipramine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00106	0.00758	CcSEcCtD
Trimipramine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00106	0.00757	CcSEcCtD
Trimipramine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00106	0.00757	CcSEcCtD
Trimipramine—Headache—Spironolactone—dilated cardiomyopathy	0.00106	0.00756	CcSEcCtD
Trimipramine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00105	0.00753	CcSEcCtD
Trimipramine—Agitation—Furosemide—dilated cardiomyopathy	0.00103	0.00739	CcSEcCtD
Trimipramine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00101	0.00721	CcSEcCtD
Trimipramine—Nausea—Spironolactone—dilated cardiomyopathy	0.001	0.00717	CcSEcCtD
Trimipramine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000965	0.0069	CcSEcCtD
Trimipramine—Benazepril—ACE—dilated cardiomyopathy	0.00095	0.105	CrCbGaD
Trimipramine—Dry mouth—Furosemide—dilated cardiomyopathy	0.000937	0.0067	CcSEcCtD
Trimipramine—Confusional state—Furosemide—dilated cardiomyopathy	0.000926	0.00662	CcSEcCtD
Trimipramine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.00091	0.101	CrCbGaD
Trimipramine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000904	0.00646	CcSEcCtD
Trimipramine—Flushing—Lisinopril—dilated cardiomyopathy	0.0009	0.00644	CcSEcCtD
Trimipramine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000899	0.00643	CcSEcCtD
Trimipramine—Anorexia—Furosemide—dilated cardiomyopathy	0.000875	0.00626	CcSEcCtD
Trimipramine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000866	0.00619	CcSEcCtD
Trimipramine—Hypotension—Furosemide—dilated cardiomyopathy	0.000858	0.00614	CcSEcCtD
Trimipramine—Alopecia—Lisinopril—dilated cardiomyopathy	0.000857	0.00613	CcSEcCtD
Trimipramine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000827	0.00591	CcSEcCtD
Trimipramine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000824	0.0059	CcSEcCtD
Trimipramine—Somnolence—Furosemide—dilated cardiomyopathy	0.000816	0.00584	CcSEcCtD
Trimipramine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000798	0.00571	CcSEcCtD
Trimipramine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000796	0.00569	CcSEcCtD
Trimipramine—Fatigue—Furosemide—dilated cardiomyopathy	0.000792	0.00566	CcSEcCtD
Trimipramine—Tremor—Lisinopril—dilated cardiomyopathy	0.000791	0.00566	CcSEcCtD
Trimipramine—Constipation—Furosemide—dilated cardiomyopathy	0.000785	0.00561	CcSEcCtD
Trimipramine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000783	0.0056	CcSEcCtD
Trimipramine—Malaise—Lisinopril—dilated cardiomyopathy	0.000761	0.00544	CcSEcCtD
Trimipramine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000757	0.00541	CcSEcCtD
Trimipramine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000746	0.00533	CcSEcCtD
Trimipramine—Urticaria—Furosemide—dilated cardiomyopathy	0.000729	0.00522	CcSEcCtD
Trimipramine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000726	0.00519	CcSEcCtD
Trimipramine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000726	0.00519	CcSEcCtD
Trimipramine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000716	0.00512	CcSEcCtD
Trimipramine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00071	0.00508	CcSEcCtD
Trimipramine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000703	0.00503	CcSEcCtD
Trimipramine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000695	0.00497	CcSEcCtD
Trimipramine—Oedema—Lisinopril—dilated cardiomyopathy	0.000689	0.00493	CcSEcCtD
Trimipramine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000675	0.00482	CcSEcCtD
Trimipramine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000672	0.00481	CcSEcCtD
Trimipramine—Asthenia—Furosemide—dilated cardiomyopathy	0.000659	0.00471	CcSEcCtD
Trimipramine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000657	0.0047	CcSEcCtD
Trimipramine—Pruritus—Furosemide—dilated cardiomyopathy	0.00065	0.00465	CcSEcCtD
Trimipramine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000644	0.0046	CcSEcCtD
Trimipramine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000628	0.00449	CcSEcCtD
Trimipramine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000623	0.00446	CcSEcCtD
Trimipramine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000619	0.00442	CcSEcCtD
Trimipramine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000612	0.00438	CcSEcCtD
Trimipramine—ADRA1A—heart—dilated cardiomyopathy	0.00061	0.0282	CbGeAlD
Trimipramine—Dizziness—Furosemide—dilated cardiomyopathy	0.000607	0.00434	CcSEcCtD
Trimipramine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000606	0.00434	CcSEcCtD
Trimipramine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000599	0.00428	CcSEcCtD
Trimipramine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000594	0.00425	CcSEcCtD
Trimipramine—Constipation—Lisinopril—dilated cardiomyopathy	0.000589	0.00421	CcSEcCtD
Trimipramine—Vomiting—Furosemide—dilated cardiomyopathy	0.000584	0.00417	CcSEcCtD
Trimipramine—Rash—Furosemide—dilated cardiomyopathy	0.000579	0.00414	CcSEcCtD
Trimipramine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000578	0.00414	CcSEcCtD
Trimipramine—Headache—Furosemide—dilated cardiomyopathy	0.000575	0.00411	CcSEcCtD
Trimipramine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000568	0.00406	CcSEcCtD
Trimipramine—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.000554	0.0613	CrCbGaD
Trimipramine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000547	0.00391	CcSEcCtD
Trimipramine—Nausea—Furosemide—dilated cardiomyopathy	0.000545	0.0039	CcSEcCtD
Trimipramine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000545	0.00389	CcSEcCtD
Trimipramine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000545	0.00389	CcSEcCtD
Trimipramine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000494	0.00353	CcSEcCtD
Trimipramine—Desipramine—SLC22A5—dilated cardiomyopathy	0.000493	0.0546	CrCbGaD
Trimipramine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000487	0.00349	CcSEcCtD
Trimipramine—CYP2C9—heart—dilated cardiomyopathy	0.000479	0.0221	CbGeAlD
Trimipramine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000471	0.00337	CcSEcCtD
Trimipramine—ADRA2A—heart—dilated cardiomyopathy	0.000464	0.0214	CbGeAlD
Trimipramine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000456	0.00326	CcSEcCtD
Trimipramine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000438	0.00313	CcSEcCtD
Trimipramine—Rash—Lisinopril—dilated cardiomyopathy	0.000434	0.00311	CcSEcCtD
Trimipramine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000434	0.0031	CcSEcCtD
Trimipramine—Headache—Lisinopril—dilated cardiomyopathy	0.000432	0.00309	CcSEcCtD
Trimipramine—Nausea—Lisinopril—dilated cardiomyopathy	0.000409	0.00293	CcSEcCtD
Trimipramine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000397	0.0183	CbGeAlD
Trimipramine—HTR2A—heart—dilated cardiomyopathy	0.000395	0.0182	CbGeAlD
Trimipramine—Desipramine—ADRB1—dilated cardiomyopathy	0.000341	0.0377	CrCbGaD
Trimipramine—Desipramine—ADRB2—dilated cardiomyopathy	0.000286	0.0317	CrCbGaD
Trimipramine—ABCB1—heart—dilated cardiomyopathy	0.000259	0.0119	CbGeAlD
Trimipramine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.33e-05	0.000371	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.33e-05	0.000371	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.29e-05	0.000368	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.28e-05	0.000367	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.27e-05	0.000366	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	4.27e-05	0.000366	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.27e-05	0.000366	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.23e-05	0.000363	CbGpPWpGaD
Trimipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	4.23e-05	0.000363	CbGpPWpGaD
Trimipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	4.22e-05	0.000362	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.21e-05	0.000361	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.21e-05	0.000361	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.19e-05	0.00036	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.18e-05	0.000358	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.16e-05	0.000357	CbGpPWpGaD
Trimipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	4.14e-05	0.000355	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.09e-05	0.000351	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.05e-05	0.000348	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.03e-05	0.000346	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.03e-05	0.000345	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.02e-05	0.000345	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.02e-05	0.000345	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.02e-05	0.000344	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.99e-05	0.000343	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	3.99e-05	0.000342	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.94e-05	0.000338	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.92e-05	0.000337	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.89e-05	0.000334	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.88e-05	0.000333	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.85e-05	0.00033	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.82e-05	0.000328	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.82e-05	0.000328	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.81e-05	0.000327	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.79e-05	0.000325	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.74e-05	0.000321	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	3.73e-05	0.00032	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.72e-05	0.000319	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.66e-05	0.000314	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.66e-05	0.000314	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.66e-05	0.000314	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.65e-05	0.000313	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.64e-05	0.000312	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.58e-05	0.000307	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.56e-05	0.000305	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.53e-05	0.000302	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.49e-05	0.000299	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	3.48e-05	0.000298	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.48e-05	0.000298	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.47e-05	0.000298	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.46e-05	0.000297	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.43e-05	0.000294	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.41e-05	0.000293	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.41e-05	0.000292	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.4e-05	0.000291	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.4e-05	0.000291	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.37e-05	0.000289	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.37e-05	0.000289	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.35e-05	0.000287	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.33e-05	0.000285	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.28e-05	0.000281	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.27e-05	0.000281	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.27e-05	0.00028	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.26e-05	0.00028	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.25e-05	0.000279	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.25e-05	0.000279	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.23e-05	0.000277	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.23e-05	0.000277	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.23e-05	0.000277	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.22e-05	0.000276	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.18e-05	0.000273	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.16e-05	0.000271	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.16e-05	0.000271	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.16e-05	0.000271	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.13e-05	0.000269	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.12e-05	0.000268	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.12e-05	0.000267	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.1e-05	0.000266	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.1e-05	0.000266	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.1e-05	0.000266	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.1e-05	0.000266	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	3.09e-05	0.000265	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.03e-05	0.00026	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.02e-05	0.000259	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.01e-05	0.000258	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.01e-05	0.000258	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3e-05	0.000257	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.98e-05	0.000255	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.97e-05	0.000255	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.97e-05	0.000254	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	2.96e-05	0.000254	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.96e-05	0.000254	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.96e-05	0.000254	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.93e-05	0.000251	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.93e-05	0.000251	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.92e-05	0.000251	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.91e-05	0.00025	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.9e-05	0.000249	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.88e-05	0.000247	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.88e-05	0.000247	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.88e-05	0.000247	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.85e-05	0.000245	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.85e-05	0.000245	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.84e-05	0.000243	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.83e-05	0.000243	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	2.83e-05	0.000243	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.83e-05	0.000242	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.81e-05	0.000241	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.81e-05	0.000241	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.8e-05	0.00024	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.8e-05	0.00024	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.79e-05	0.000239	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.79e-05	0.000239	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.77e-05	0.000238	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.77e-05	0.000238	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.75e-05	0.000236	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.75e-05	0.000236	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.74e-05	0.000235	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.74e-05	0.000235	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.73e-05	0.000234	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.7e-05	0.000231	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.69e-05	0.000231	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.69e-05	0.00023	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.66e-05	0.000229	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.65e-05	0.000228	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.64e-05	0.000226	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.63e-05	0.000226	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.61e-05	0.000224	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.61e-05	0.000224	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.61e-05	0.000223	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.59e-05	0.000222	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.58e-05	0.000221	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.57e-05	0.000221	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.57e-05	0.00022	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.57e-05	0.00022	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.56e-05	0.000219	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.56e-05	0.000219	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.56e-05	0.000219	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.53e-05	0.000217	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.52e-05	0.000216	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.52e-05	0.000216	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.5e-05	0.000214	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.49e-05	0.000213	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.48e-05	0.000212	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	2.47e-05	0.000212	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.46e-05	0.000211	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.45e-05	0.00021	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.4e-05	0.000206	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.38e-05	0.000204	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.38e-05	0.000204	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.37e-05	0.000203	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.36e-05	0.000202	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	2.36e-05	0.000202	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.34e-05	0.000201	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.3e-05	0.000197	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.26e-05	0.000194	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.2e-05	0.000188	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.16e-05	0.000185	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.16e-05	0.000185	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.14e-05	0.000184	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.11e-05	0.000181	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.11e-05	0.000181	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.08e-05	0.000179	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.07e-05	0.000177	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.06e-05	0.000176	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.05e-05	0.000176	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.04e-05	0.000175	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.04e-05	0.000175	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.03e-05	0.000174	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.01e-05	0.000172	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.97e-05	0.000169	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.97e-05	0.000169	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.94e-05	0.000166	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.91e-05	0.000164	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.9e-05	0.000163	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.89e-05	0.000162	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.86e-05	0.00016	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.84e-05	0.000158	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.84e-05	0.000158	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.83e-05	0.000157	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.82e-05	0.000156	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.81e-05	0.000156	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.79e-05	0.000153	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.79e-05	0.000153	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.78e-05	0.000153	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.76e-05	0.000151	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.76e-05	0.000151	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.76e-05	0.000151	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.75e-05	0.00015	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.75e-05	0.00015	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.75e-05	0.00015	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.72e-05	0.000148	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.69e-05	0.000145	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.68e-05	0.000144	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	1.65e-05	0.000142	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	1.64e-05	0.00014	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.62e-05	0.000139	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.62e-05	0.000139	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.6e-05	0.000137	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.59e-05	0.000136	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.59e-05	0.000136	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.56e-05	0.000134	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	1.54e-05	0.000132	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.52e-05	0.00013	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	1.52e-05	0.00013	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.49e-05	0.000128	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.47e-05	0.000126	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.45e-05	0.000124	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.42e-05	0.000122	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.41e-05	0.000121	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.38e-05	0.000119	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.35e-05	0.000116	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.34e-05	0.000115	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.3e-05	0.000112	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.3e-05	0.000112	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.27e-05	0.000109	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.26e-05	0.000108	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.24e-05	0.000107	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.23e-05	0.000105	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.22e-05	0.000105	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.22e-05	0.000105	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.22e-05	0.000105	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.22e-05	0.000104	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.21e-05	0.000104	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.2e-05	0.000103	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.2e-05	0.000103	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.19e-05	0.000102	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	0.0001	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.16e-05	9.97e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.14e-05	9.81e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.12e-05	9.63e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.11e-05	9.55e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.08e-05	9.24e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.07e-05	9.19e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.07e-05	9.16e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.05e-05	9.05e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.05e-05	9.03e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.03e-05	8.86e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	9.6e-06	8.23e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	8.67e-06	7.44e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	8.37e-06	7.18e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	8.33e-06	7.14e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	8.03e-06	6.89e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.97e-06	6.84e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	7.83e-06	6.71e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	7.35e-06	6.31e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.23e-06	6.2e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.22e-06	6.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.08e-06	6.07e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	7.05e-06	6.04e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.58e-06	5.64e-05	CbGpPWpGaD
